Diabetes Outcomes Panel
Manage high-risk cohort performance.
Realized Bonus
$2,400
Target: $6,000
+12%/ mo
Active Cohort
5
Type 2 Diabetes
0%/ mo
Critical Attention
1
Immediate Action Req.
+2/ mo
| Patient | Risk Profile | Current HbA1c | Trend | Next Action |
|---|---|---|---|---|
JW James Wilson Last review: 2025-09-15 | Medium | 7.2% | ↘ Improving | |
MG Maria Garcia Last review: 2025-11-01 | Low | 6.5% | → Stable | |
RC Robert Chen Last review: 2025-08-10 | Critical | 9.1% | ↗ Rising | |
SM Sarah Miller Last review: 2025-10-05 | High | 8.4% | → Stable | |
DK David Kumar Last review: 2025-11-15 | Low | 6.8% | ↘ Improving |
JW
James Wilson
Type 2 Diabetes
HbA1c
7.2%↘
Revenue
Potential: $1200
MG
Maria Garcia
Type 2 Diabetes
HbA1c
6.5%
Revenue
Potential: $1200
RC
Robert Chen
Type 2 Diabetes
HbA1c
9.1%↗
Revenue
Potential: $1200
SM
Sarah Miller
Type 2 Diabetes
HbA1c
8.4%
Revenue
Potential: $1200
DK
David Kumar
Type 2 Diabetes
HbA1c
6.8%↘
Revenue
Potential: $1200